ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 302325 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 302325; 2) Community: the network communities that were significantly associated with the response to NSC 302325; 3) Molecule: the relationships between components within communities and NSC 302325; 4) MDR: the compounds that were significantly associated with the NSC 302325.

NSC Compound Enrichment Correlation
NSC 280074 Ethanol, 2,2'-[[4-[[[4-[2-(phenoxymethyl)-4-thiazolyl]phenyl]imino]methyl]phenyl]imino]bis-, dimethanesulfonate (ester) 0.0339770934764516 0.27293136
NSC 290193 CYCLOSPORIN A 0.0339770934764516 0.27804181
NSC 293046 Carbamimidothioic acid, (4-oxo-2-phenyl-4H-1-benzopyran-8-yl)methyl ester, monohydrobromide 0.0339770934764516 0.11599011
NSC 143241 Dibenzo[de,g]quinoline-6-carboxylic acid, 4,5-dihydro- 1,2,9,10-tetramethoxy-, ethyl ester 0.035202825328704 0.38462656
NSC 305802 2,4-Quinazolinediamine, 5,6,7,8-tetrahydro-6-(2-naphthalenylsulfonyl)- 0.0352028253287042 0.75756055
NSC 326408 Rocaglamide (FR AGLAIA ELLIPTIFOLIA) 0.0352028253287042 0.51317266
NSC 329277 Null 0.0352028253287042 0.20817278
NSC 329515 Kijanimicin sodium salt 0.0352028253287042 0.33165099
NSC 330753 Baccatin III 0.0352028253287042 0.24274898
NSC 33092 Null 0.0352028253287042 0.4385001
Total:151  Current:115    [First] [Prev] [Next] [Last]